Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Paxman AB (publ)

PXMBFPNK
Healthcare
Medical - Devices
$3.50
$0.00(0.00%)
U.S. Market opens in 14h 47m

Paxman AB (publ) Fundamental Analysis

Paxman AB (publ) (PXMBF) shows weak financial fundamentals with a PE ratio of 145.20, profit margin of 1.64%, and ROE of 1.49%. The company generates $0.6B in annual revenue with strong year-over-year growth of 20.41%.

Key Strengths

Cash Position166.72%
PEG Ratio-0.38
Current Ratio4.68

Areas of Concern

ROE1.49%
Operating Margin4.99%
We analyze PXMBF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 52.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
52.1/100

We analyze PXMBF's fundamental strength across five key dimensions:

Efficiency Score

Weak

PXMBF struggles to generate sufficient returns from assets.

ROA > 10%
0.99%

Valuation Score

Moderate

PXMBF shows balanced valuation metrics.

PE < 25
145.20
PEG Ratio < 2
-0.38

Growth Score

Moderate

PXMBF shows steady but slowing expansion.

Revenue Growth > 5%
20.41%
EPS Growth > 10%
3.80%

Financial Health Score

Excellent

PXMBF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
4.68

Profitability Score

Weak

PXMBF struggles to sustain strong margins.

ROE > 15%
149.23%
Net Margin ≥ 15%
1.64%
Positive Free Cash Flow
No

Key Financial Metrics

Is PXMBF Expensive or Cheap?

P/E Ratio

PXMBF trades at 145.20 times earnings. This suggests a premium valuation.

145.20

PEG Ratio

When adjusting for growth, PXMBF's PEG of -0.38 indicates potential undervaluation.

-0.38

Price to Book

The market values Paxman AB (publ) at 1.64 times its book value. This may indicate undervaluation.

1.64

EV/EBITDA

Enterprise value stands at 35.51 times EBITDA. This signals the market has high growth expectations.

35.51

How Well Does PXMBF Make Money?

Net Profit Margin

For every $100 in sales, Paxman AB (publ) keeps $1.64 as profit after all expenses.

1.64%

Operating Margin

Core operations generate 4.99 in profit for every $100 in revenue, before interest and taxes.

4.99%

ROE

Management delivers $1.49 in profit for every $100 of shareholder equity.

1.49%

ROA

Paxman AB (publ) generates $0.99 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.99%

Following the Money - Real Cash Generation

Operating Cash Flow

Paxman AB (publ) generates limited operating cash flow of $31.44M, signaling weaker underlying cash strength.

$31.44M

Free Cash Flow

Paxman AB (publ) generates weak or negative free cash flow of $-9.99M, restricting financial flexibility.

$-9.99M

FCF Per Share

Each share generates $-0.23 in free cash annually.

$-0.23

FCF Yield

PXMBF converts -0.38% of its market value into free cash.

-0.38%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

145.20

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.38

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.64

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.58

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.68

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.01

vs 25 benchmark

ROA

Return on assets percentage

0.010

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How PXMBF Stacks Against Its Sector Peers

MetricPXMBF ValueSector AveragePerformance
P/E Ratio145.2029.45 Worse (Expensive)
ROE1.49%779.00% Weak
Net Margin1.64%-24930.00% (disorted) Weak
Debt/Equity0.030.26 Strong (Low Leverage)
Current Ratio4.684.65 Strong Liquidity
ROA0.99%-19333.00% (disorted) Weak

PXMBF outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Paxman AB (publ)'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

149.87%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

1128.35%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

896.48%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ